A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
Titel:
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
Auteur:
Gruber, Astrid Björkholm, Magnus Brinch, Lorentz Evensen, Stein Gustavsson, Bengt Hedenus, Michael Juliusson, Gunnar Löfvenberg, Eva Nesthus, Ingerid Simonsson, Bengt Sjo, Malvin Stenke, Leif Tangen, Jon Magnus Tidefelt, Ulf Udén, Ann-Mari Paul, Christer Liliemark, Jan